Revolution Medicines Prepares for Solo European Launch of Cancer Drug
Revolution Medicines is laying groundwork for a broad European commercial rollout of its pancreatic cancer drug without a local sales partner.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.